AMA approves CPT code for Axxent electronic brachytherapy
AMA approves CPT code for Axxent electronic brachytherapy
FREMONT, CaliforniaXoft, Inc., maker of the FDA-approved Axxent Electronic Brachytherapy System (see Oncology NEWS International, June 2007, page 34) has announced that Axxent treatment now has a CPT reimbursement code. The American Medical Association CPT Editorial Panel approved the code (Category III CPT Code 0182T) for this novel form of high-dose-rate radiation therapy for the treatment of early-stage breast cancer. The code has been assigned a New Technology Ambulatory Payment Classification (APC), which secures payment for Medicare recipients who receive the treatment in the hospital outpatient setting.
Articles in this issue
Avoiding copay shock
Induction chemo increases survival in unresectable NSCLC
Superselective chemo strategies for HCC
'Value meal dosing' of lapatinib is proposed
AMA approves CPT code for Axxent electronic brachytherapy
Zevalin/R after CHOP-R doubles CRs in follicular NHL
Active surveillance with delayed treatment appears to be a safe option for younger men with low-risk prostate cancer
RT plus local paclitaxel gel promising in esophageal ca
GeneSearch BLN Assay gets FDA approval for node assessment during surgery
TH vs TCH in metastatic breast cancer: 'Take your pick'
Sunitinib prolongs PFS in RCC: update
Diagnostic Dilemma: GI Disease
ACS studies link patients' insurance status to cancer outcomes
Novel MAGE-A3 immunotherapeutic promising as adjuvant therapy of early-stage non-small-cell lung ca
US consumers are shielded from the cost of healthcare
Recent Videos
Related Content
